Company
Apnimed, Inc.
| Industry | pharmaceutical company developing novel oral therapies for obstructive sleep apnea (OSA) |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Apnimed, Inc. | Debt Financing | 2026-04-06 |
| Apnimed, Inc. | Series C Extension | 2023-01-04 |
Company
| Industry | pharmaceutical company developing novel oral therapies for obstructive sleep apnea (OSA) |
|---|
| Company | Round | Date |
|---|---|---|
| Apnimed, Inc. | Debt Financing | 2026-04-06 |
| Apnimed, Inc. | Series C Extension | 2023-01-04 |